Surmodics Investor Relations Material
Latest events
Q2 2024
Surmodics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Surmodics Inc
Access all reports
Surmodics Inc is a global enterprise that provides surface modification technologies for intravascular medical device components, chemical components for in vitro diagnostic (IVD) immunoassay tests and microarrays, as well as laser equipment for laboratory-scale research applications. Surmodics Inc scientific expertise spans the breadth of the surface modification field, from surface activated chemistry to surface functionalization of microfluidic devices, with a focus on critical quality attributes like biocompatibility.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
SRDX
Country
🇺🇸 United States